Surge in incidence of venous thromboembolism and cardiovascular disorders, rise in use of heparin in surgical procedures, and increase in geriatric populations drive the growth of the global heparin market. The market across Asia-Pacific is projected to portray the highest CAGR of 7.8% during the forecast period